Furthermore, the induced expression of RBX1 in myeloma cells was more sensitive to treatment with specific chemotherapeutic drugs, whereas the introduction of p27Res or p27T187A but not p27S10A completely abrogated the inhibition of myeloma cell death and growth, which was induced by RBX1 overexpression. The gene discussed is RBX1; the disease is plasma cell myeloma.